Omeclamox-pak
Product Images NDC 66220-422

4 FDA label images from Cumberland Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Omeclamox-pak (NDC 66220-422). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cumberland Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ome08 0003 01

Ome08 0003 01
Chemical structure diagram of the active ingredient in Omeclamox-Pak, showing the molecular arrangement with labeled bonds and atoms typical of the compound's chemical formula.*
FDA Label Image

Ome08 0003 02

Ome08 0003 02
Chemical structure diagram of the active ingredient in Omeclamox-Pak, depicting its molecular arrangement with multiple ring systems and various functional groups, including oxygen and methyl groups.*
FDA Label Image

Ome08 0003 03

Ome08 0003 03
Chemical structure of the active ingredient from Omeclamox-Pak, shown as a detailed molecular diagram including atoms and bonds with stereochemical notations and hydration (3 H2O).*
FDA Label Image

Ome08 0003 04

Ome08 0003 04
Label for Omeclamox-Pak triple therapy by Cumberland Pharmaceuticals Inc., listing active ingredients omeprazole, clarithromycin, and amoxicillin. It specifies omeprazole delayed-release capsules 20 mg, clarithromycin tablets 500 mg, and amoxicillin capsules 500 mg. The label details the capsule and tablet descriptions in a daily patient card pack of 10, marked Rx Only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.